Aptevo Therapeutics Inc. Increase (Decrease) in Inventories
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Inventories of $4.35 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2020-11-10
- Aptevo Therapeutics Inc. increase (decrease) in inventories for the quarter ending 2019-12-31 was -$1.34M.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for the quarter ending 2019-09-30 was $515.00K, a 48.45% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for the quarter ending 2019-06-30 was $2.62M, a 55.55% increase year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for the quarter ending 2019-03-31 was $2.56M, a 896.50% increase year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for fiscal 2019 was $4.35M, a 475.17% increase from fiscal 2018.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for fiscal 2018 was $757.00K, a 33.51% increase from fiscal 2017.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for fiscal 2017 was $567.00K.
- Aptevo Therapeutics Inc. increase (decrease) in inventories for fiscal 2016 was -$13.68M, a 607.34% decline from fiscal 2015.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$828.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.79M derived: sum of 3 quarters · filed 2020-11-10 | $4.35M 10-K · filed 2020-03-25 | ||
| 2019-09-30 | $515.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $3.14M derived: sum of 2 quarters · filed 2020-11-10 | $5.70M 10-Q · filed 2020-11-10 | $3.51M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $5.18M 10-Q · filed 2020-08-14 | $3.00M derived: sum of 3 quarters · filed 2020-08-14 | $4.00M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $2.56M 10-Q · filed 2020-05-13 | $377.00K derived: sum of 2 quarters · filed 2020-05-13 | $1.38M derived: sum of 3 quarters · filed 2020-05-13 | $3.06M derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$1.19M derived: sum of 2 quarters · filed 2020-03-25 | $500.00K derived: sum of 3 quarters · filed 2020-03-25 | $757.00K 10-K · filed 2020-03-25 | ||
| 2018-09-30 | $999.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.68M derived: sum of 2 quarters · filed 2019-11-07 | $2.94M 10-Q · filed 2019-11-07 | $2.73M derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.94M 10-Q · filed 2019-08-09 | $1.73M derived: sum of 3 quarters · filed 2019-08-09 | $1.04M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $257.00K 10-Q · filed 2019-05-09 | $48.00K derived: sum of 2 quarters · filed 2019-05-09 | -$643.00K derived: sum of 3 quarters · filed 2019-05-09 | -$518.00K derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$900.00K derived: sum of 2 quarters · filed 2019-03-18 | -$775.00K derived: sum of 3 quarters · filed 2019-03-18 | $567.00K 10-K · filed 2019-03-18 | ||
| 2017-09-30 | -$691.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$566.00K derived: sum of 2 quarters · filed 2018-11-14 | $776.00K 10-Q · filed 2018-11-14 | -$4.16M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.47M 10-Q · filed 2018-08-09 | $1.34M 10-Q · filed 2017-08-10 | -$3.47M derived: sum of 3 quarters · filed 2018-08-09 | -$12.02M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | $1.34M 10-Q · filed 2018-05-10 | $1.42M 10-Q · filed 2017-05-12 | -$3.59M derived: sum of 2 quarters · filed 2018-05-10 | -$12.15M derived: sum of 3 quarters · filed 2018-05-10 | -$14.09M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | -$4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$13.49M derived: sum of 2 quarters · filed 2018-03-13 | -$15.43M derived: sum of 3 quarters · filed 2018-03-13 | -$13.68M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | -$8.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$10.50M derived: sum of 2 quarters · filed 2017-11-13 | -$8.75M 10-Q · filed 2017-11-13 | -$10.14M derived: sum of 4 quarters · filed 2017-11-13 | ||
| 2016-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$192.00K 10-Q · filed 2017-08-10 | -$1.59M derived: sum of 3 quarters · filed 2017-08-10 | -$412.00K derived: sum of 4 quarters · filed 2017-08-10 | ||
| 2016-03-31 | $1.75M 10-Q · filed 2017-05-12 | $353.00K derived: sum of 2 quarters · filed 2017-05-12 | $1.53M derived: sum of 3 quarters · filed 2017-05-12 | |||
| 2015-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$220.00K derived: sum of 2 quarters · filed 2017-03-31 | $2.70M 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $1.18M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $4.09M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $2.92M 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |